Celtaxsys, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Atlanta GA United States (2004)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2012
NCT01748838
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Celtaxsys Aus Pty Limited | Celtaxsys, Inc.